Cargando…

Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis

IMPORTANCE: The outcomes and factors that influence survival in patients with oligometastasis (OM) are not well understood and have not been well described in large-scale studies. OBJECTIVE: To evaluate overall progression-free survival (PFS), widespread progression (WSP) outcomes, and survival fact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poon, Ian, Erler, Darby, Dagan, Roi, Redmond, Kristin J., Foote, Matthew, Badellino, Serena, Biswas, Tithi, Louie, Alexander V., Lee, Young, Atenafu, Eshetu G., Ricardi, Umberto, Sahgal, Arjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670310/ https://www.ncbi.nlm.nih.gov/pubmed/33196810 http://dx.doi.org/10.1001/jamanetworkopen.2020.26312

Ejemplares similares

Late metastatic presentation is associated with improved survival and delayed wide‐spread progression after ablative stereotactic body radiotherapy for oligometastasis
por: Chen, Xuguang, et al.
Publicado: (2021)

Volumetric burden of metastatic lesions drives outcomes in patients with extracranial oligometastatic disease
por: Cao, Yilin, et al.
Publicado: (2021)

Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study
por: Baydoun, A., et al.
Publicado: (2021)

Stereotactic Radiotherapy for Oligometastasis
por: Otake, Sotaro, et al.
Publicado: (2019)

Stereotactic radiotherapy for early stage non-small cell lung cancer
por: Ricardi, Umberto, et al.
Publicado: (2015)

Adrenal oligometastasis cured with stereotactic ablative radiotherapy
por: Malone, Julia, et al.
Publicado: (2020)

Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach
por: Ricardi, Umberto, et al.
Publicado: (2016)

Stereotactic spine radiosurgery: Review of safety and efficacy with respect to dose and fractionation
por: Huo, Michael, et al.
Publicado: (2017)

Diagnosis of oligometastasis
por: Terao, Mayako, et al.
Publicado: (2020)

To frame or not to frame? Cone‐beam CT‐based analysis of head immobilization devices specific to linac‐based stereotactic radiosurgery and radiotherapy
por: Babic, Steven, et al.
Publicado: (2018)

microRNAs and oligometastasis
por: Khodarev, Nikolai N., et al.
Publicado: (2015)

BIOMARKER STATUS PREDICTS FOR LOCAL CONTROL (LC) FOLLOWING SPINE STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH SPINAL METASTASES
por: Shor, Dana, et al.
Publicado: (2023)

Oligometastasis: More Lessons to Be Learned
por: Kim, Kyung Hwan, et al.
Publicado: (2023)

Real-Time Tumor-Tracking Radiotherapy and General Stereotactic Body Radiotherapy for Adrenal Metastasis in Patients With Oligometastasis
por: Katoh, Norio, et al.
Publicado: (2018)

Stereotactic Body Radiotherapy in Contralateral Kidney Oligometastasis From Renal Cell Carcinoma in a Nephrectomized Patient
por: Marzo, Alessandro Di, et al.
Publicado: (2021)

Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events
por: Zeng, K Liang, et al.
Publicado: (2021)

Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events
por: Zeng, K Liang, et al.
Publicado: (2021)

Evaluation of the Efficacy of Rotational Corrections for Standard-Fractionation Head and Neck Image-Guided Radiotherapy
por: Kung, Joseph S., et al.
Publicado: (2019)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
por: Gutschenritter, Tyler, et al.
Publicado: (2020)

Metastasis-directed therapy for oligometastasis and beyond
por: Beckham, Thomas H., et al.
Publicado: (2020)

Optimal Definition of Oligometastasis Showing Survival Benefits of Local Therapies during Tyrosine Kinase Inhibitor Treatment
por: Jang, Yoon Jung, et al.
Publicado: (2023)

Extracranial doses in stereotactic and conventional radiotherapy for pituitary adenomas
por: Ram, Thomas Samuel, et al.
Publicado: (2006)

Technical know‐how in stereotactic ablative radiotherapy (SABR)
por: Lo, Simon S., et al.
Publicado: (2016)

STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR SACRAL METASTASES: DEVIATION FROM RECOMMENDED TARGET VOLUME DELINEATION PREDICTS HIGHER RISK OF LOCAL FAILURE
por: Moore-Palhares, Daniel, et al.
Publicado: (2023)

30 GY IN 4 STEREOTACTIC BODY RADIOTHERAPY (SBRT) FRACTIONS FOR COMPLEX SPINAL METASTASES: MATURE OUTCOMES SUPPORTING THIS NOVEL REGIMEN
por: Moore-Palhares, Daniel, et al.
Publicado: (2023)

Role of Radiosurgery and Stereotactic Ablative Radiotherapy for Oligometastatic Non-Oncogene Addicted NSCLC
por: Badellino, Serena, et al.
Publicado: (2022)

MicroRNA Expression Characterizes Oligometastasis(es)
por: Lussier, Yves A., et al.
Publicado: (2011)

Oligometastasis: Expansion of Curative Treatments in the Field of Oncology
por: Lim, Ah Reum, et al.
Publicado: (2023)

Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
por: Weykamp, Fabian, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy (SBRT) for an Extracranial Arteriovenous Malformation of the Pelvis
por: Jooya, Alborz, et al.
Publicado: (2021)

Oligometastasis and oligo-recurrence: more than a mirage
por: Huang, Fang, et al.
Publicado: (2014)

Oligometastasis and local ablation in the era of systemic targeted and immunotherapy
por: Mazzola, Rosario, et al.
Publicado: (2020)

Barriers in Oligometastasis Care in Korea: Radiation Oncologists’ Perspectives
por: Chie, Eui Kyu, et al.
Publicado: (2023)

OLIGOMETASTASIS IN GASTRIC CANCER TREATMENT: IS THERE A PLACE FOR THE SURGEON?
por: de ASSUMPÇÃO, Paulo Pimentel, et al.
Publicado: (2023)

Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases
por: Soliman, Hany, et al.
Publicado: (2016)

Long-term Local Control of Primary Non-small Cell Lung Cancer and Adrenal Oligometastasis with Stereotactic Body Radiotherapy: A Case Report
por: Krzywicki, Victoria, et al.
Publicado: (2019)

Modern Radiation Therapy for the Management of Brain Metastases From Non-Small Cell Lung Cancer: Current Approaches and Future Directions
por: Mantovani, Cristina, et al.
Publicado: (2021)

Lung Radiofrequency Ablation: Potential as a Therapy to Oligometastasis and Oligorecurrence
por: Hiraki, Takao, et al.
Publicado: (2012)

Prognostic Utility of Histological Growth Patterns of Colorectal Lung Oligometastasis
por: Yeong, Son Jae, et al.
Publicado: (2018)

Revisiting a Null Hypothesis: Exploring the Parameters of Oligometastasis Treatment
por: Scarborough, Jessica A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_30t9co68el8dvu0rijisnrqi2g